1. Agency for Clinical Innovation (2018) Consumer Enablement Guide: Shared Decision Making. aci.health.nsw.gov.au/projects/consumer-enablement/how-to-support-enablement/shared-decision-making (Last accessed: 21 November 2023.)
2. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults;American Geriatrics Society Beers Criteria Update Expert Panel;Journal of the American Geriatrics Society,2023
3. Co-morbidity and drug treatment in Alzheimer’s disease. A cross sectional study of participants in the Dementia Study in Northern Norway;BMC Geriatrics,2011
4. Australian Royal Commission on Safety and Quality in Health Care (2023a) Medication Safety Standard. www.safetyandquality.gov.au/standards/nsqhs-standards/medication-safety-standard (Last accessed: 21 November 2023.)
5. Australian Royal Commission on Safety and Quality in Health Care (2023b) Psychotropic Medicines in Cognitive Disability or Impairment: Clinical Care Standard. Guide for Consumers. www.safetyandquality.gov.au/sites/default/files/2023-04/guide_for_consumers_-_public_consultation_-_april_2023.pdf (Last accessed: 21 November 2023.)